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Background: The mechanism of heat-induced irreversible denaturation of a single domain VHH camelid antibody remains
unclear.
Results: The denaturation of VHH did not depend on the number of refolding/unfolding reactions or protein concentration.
Mutations replacing Asn increased the heat tolerance of VHH.
Conclusion: Chemical modifications are suggested to be a dominant factor for irreversible denaturation of VHH.
Significance: Our findings enable further improvements for heat tolerance of VHH.
The variable domain of camelid heavy chain antibody (VHH)
is highly heat-resistant and is therefore ideal for many applica-
tions. Although understanding the process of heat-induced irre-
versible denaturation is essential to improve the efficacy of
VHH, its inactivation mechanism remains unclear. Here, we
showed that chemical modifications predominantly governed
the irreversible denaturation of VHH at high temperatures.
After heat treatment, the activity of VHH was dependent only on
the incubation time at 90 °C and was insensitive to the number
of heating (90 °C)-cooling (20 °C) cycles, indicating a negligible
role for folding/unfolding intermediates on permanent dena-
turation. The residual activity was independent of concentra-
tion; therefore, VHH lost its activity in a unimolecular manner,
not by aggregation. A VHH mutant lacking Asn, which is sus-
ceptible to chemical modifications, had significantly higher heat
resistance than did the wild-type protein, indicating the impor-
tance of chemical modifications to VHH denaturation.
Increasing the robustness of antibodies against heat-induced
irreversible denaturation is important for the application of
antibodies as drugs, diagnostic reagents, and biosensors (1, 2).
The variable domain of camelid heavy chain antibody (VHH)3
is a single domain antibody that originates from a natural mam-
malian antibody (3, 4). VHH is active after incubation at high
temperatures (80 °C) and is significantly more heat-resistant
than conventional antibodies (5–10). Thus, VHH is recognized
as an ideal antibody for many applications. A mechanistic
understanding of heat-induced irreversible denaturation will
help improve VHH heat resistance and the efficacy of VHH in
industrial applications; however, no information is available on
the irreversible denaturation of this fragment.
Heat-induced irreversible denaturation, defined as a perma-
nent inactivation of protein function caused by exposure to
high temperature, has been considered to mainly originate
from four factors: aggregation of folding intermediates, aggre-
gation of the unfolded state, chemical modifications, and gen-
eration of misfolded monomers (11). Although each factor has
been extensively studied, no study has precisely discriminated
the effects of these factors on the heat-induced denaturation of
antibodies. Folding intermediates often present exposed hydro-
phobic residues; thus, they are vulnerable to nonspecific aggre-
gation (12–16). Moreover, many proteins aggregate at high
temperatures (17, 18). Chemical modifications of amino acids
are also frequently observed when a protein is heated at a high
temperature (19 –25). In addition, the heating process in-
duces the formation of misfolded monomers (26), which are
formed through noncovalent aberrant interactions. A precise eval-
uation of these factors would enable us to better understand the
mechanisms of VHH heat-induced irreversible denaturation.
In this study, we first evaluated the effects of heat treatment
on the refolding and/or unfolding process by measuring the
residual activity of VHH using surface plasmon resonance
(SPR) after two types of heat treatments. In these experiments,
the samples were subjected either to repetitive 90 and 20 °C
incubations or to continuous incubation at a high temperature.
The remaining factors controlling denaturation, i.e. aggrega-
tion, misfolding, and chemical modifications of amino acids,
were assessed by a series of experiments examining various
parameters, including incubation temperature and protein
concentration. Mutations increasing heat tolerance were then
exploited. In addition, changes in biophysical properties during
the VHH denaturation process were analyzed by matrix-as-
sisted laser desorption ionization time-of-flight (MALDI-TOF)
mass spectrometry, circular dichroism (CD) spectrometry,
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and differential scanning microcalorimetry (DSC). Finally,
we identified the critical determinant of VHH heat-induced
denaturation.
EXPERIMENTAL PROCEDURES
Materials—Mouse anti-human chorionic gonadotropin (hCG)
IgG clone 207 was purchased from Wako Pure Chemical Indus-
tries, Ltd. (Osaka, Japan), and IgG clone 28A4 and IgG clone
77F12 were from HyTest, Ltd. (Turku, Finland). Single chain
variable fragment (scFv) clone 1001.1E5.E8 was from Randox
Life Sciences Co. (Antrim, UK). hCG and Bacillus cereus -lac-
tamase (penicillinase) were obtained from Sigma-Aldrich.
Preparation of VHH and Fab Fragments—Wild-type anti-
hCG (VHH-H14) and anti--lactamase (cAbBCII10) VHH syn-
thetic genes were designed using the published peptide
sequences (27–31). Construction of the expression vectors
containing anti-hCG wild-type and mutant VHHs with an arti-
ficial disulfide bond was described previously (32, 33). Asn res-
idues at positions 52, 74, and 84 of anti-hCG VHH were
replaced with Ser, Ser, and Thr, respectively, by PCR-based
site-directed mutagenesis. The resulting mutant, N52S/N74S/
N84T, was cloned into pAED4 (34). Wild-type and mutant
VHHs were expressed in Escherichia coli strain BL21(DE3)
pLysS (Stratagene, La Jolla, CA) using Lennox LB medium.
Anti-hCG VHHs were accumulated in inclusion bodies, and
anti--lactamase VHH was expressed in soluble form. Inclu-
sion bodies from 1.6 liters of culture were suspended with 3 ml
of 10 mM Tris-HCl (pH 8.5) and 100 l of 1 M dithiothreitol and
solubilized by addition of 3 g of solid guanidine hydrochloride
(Gdn-HCl). These samples were then purified on Superdex 75
columns (GE Healthcare) pre-equilibrated with 6 M urea in 10
mM Tris-HCl (pH 8.5) and subjected to overnight air oxidation
at 4 °C. A 1⁄10 volume of 1 M sodium acetate (pH 4.7) was added
to the samples, and samples were then dialyzed against 10 mM
sodium acetate (pH 4.7). A Resource S cation-exchange column
(GE Healthcare) equilibrated with 10 mM sodium acetate (pH
4.7) was used to purify crude VHHs. When anti-hCG wild-type
VHH was expressed in synthetic medium, it could be recovered
from soluble and insoluble fractions of cell extracts. The histi-
dine-tagged constructs of anti-hCG and anti--lactamase
VHHs in which the sequence of Ala-Gly-Gly-His-His-His-His-
His-His was appended to the C terminus of the sequence were
prepared, and proteins were expressed in synthetic or LB
medium. The soluble fraction and the insoluble fraction, dis-
solved in 6 M Gdn-HCl, were subjected to 5-ml HiTrap Chelat-
ing HP or HisTrap HP columns (GE Healthcare) and eluted by
a gradient of imidazole and NaCl in 20 mM Tris-HCl buffer (pH
8.5). Anti--lactamase VHH was incubated in 6 M Gdn-HCl
and 10 mM Tris-HCl (pH 8.5) overnight at room temperature to
oxidize the disulfide bond and extensively dialyzed against 10
mM Tris-HCl (pH 8.5). Formation of the disulfide bond was
confirmed by Ellman’s reagent (35). A MALDI-TOF mass spec-
trometer (Microflex AI, Bruker Daltonics Inc., Billerica, MA)
was then used to confirm that the molecular weight of the puri-
fied proteins was identical to the expected values calculated
from their amino acid sequences (with an error of 0.025%)
with an added N-terminal Met residue. Three antigen-binding
fragments (Fabs), Fab clone 207, Fab clone 28A4, and Fab clone
77F12, were prepared from IgG clone 207, IgG clone 28A4, and
IgG clone 77F12, respectively, using the Pierce Fab preparation
kit (Thermo Fisher Scientific Inc., Rockford, IL). Briefly, 0.5 mg
of IgG was treated with 0.5 ml of immobilized papain (250
g/ml of settled resin) for 18 h at 37 °C, and the Fc fragment was
removed using immobilized protein A. The concentration of
VHH in the stock solution was determined by measuring the
absorbance at 280 nm (36) using a UV-2500PC spectrophotom-
eter (Shimadzu Corp., Kyoto, Japan). The concentration of Fab
was determined by the absorption at 280 nm using an extinc-
tion coefficient of 1.4 for 1 mg/ml.
Iterative Heat-induced Heating-Cooling Cycles and Continu-
ous Incubation—Treatment of the antibodies with iterative
heating-cooling cycles was carried out using GeneAmp PCR
System 9700 and 2700 thermal cyclers (Invitrogen), a PTC-
0150 MiniCycler (Bio-Rad), and TaKaRa PCR Thermal Cycler
SP and Dice Standard (Takara Bio Inc., Shiga, Japan). Samples
in 10 mM HEPES (pH 7.4), 150 mM NaCl, 3 mM EDTA, and
0.005% surfactant P20 (HBS-EP) were divided into 160-l ali-
quots placed in 0.2-ml microtubes. Ramp speeds of thermal
cyclers ranged from 1.2 to 1.9 °C/s for heating and from 0.8 to
1.3 °C/s for cooling. To equilibrate the structural change of pro-
teins, the samples were incubated for 5 min after increase or
decrease of temperature. In typical heating-cooling cycles, sam-
ples were heated for 5 min at 90 °C and then incubated for 5 min
at 20 °C. Continuous heating experiments were also performed
under the same conditions without multiple heating-cooling
cycles (see Fig. 1A).
Measurement of the Antigen Binding Activities of VHH and
Other Antibodies—-Lactamase was purified by HisTrap HP
(GE Healthcare) equilibrated by 10 mM Tris-HCl (pH 7) and 1
mM ZnCl2 (37). Antigen hCG (0.05 mg/ml) and -lactamase
(0.025 mg/ml) were coupled to a CM5 sensor chip (GE Health-
care) in 10 mM sodium acetate buffer (pH 4.7) by amine cou-
pling according to the manufacturer’s instructions. Analysis
was performed on a Biacore 2000 instrument (GE Healthcare)
in HBS-EP buffer at 20 °C followed by regeneration with 10 mM
glycine (pH 2.0) and 0.5 M NaCl. The interaction between VHH
and hCG in this study could not be approximated by the simple
Langmuir model (33). Therefore, we estimated the residual
activity using standard curves for VHH, scFv, three Fabs, and
three IgGs (see Fig. 1, B–E). For the generation of standard
curves, the SPRs of four to five untreated intact samples with
known protein concentrations between 0.1 and 2 g/ml were
measured. The protein concentrations were plotted against
SPR values at 350 s at which the antibody association section
was almost finished. Using these standard curves, the SPR val-
ues of heat-treated samples at 350 s were converted into resid-
ual active antibody fractions. Estimated residual activity of anti-
hCG VHH using the SPR values of controls and samples at 150,
200, 250, 300, and 350 s were not significantly deviated and
were almost identical to each other within the errors (Fig. 1F).
When the sample concentration was higher than 2 g/ml, it
was diluted with HBS-EP buffer before SPR measurement. Typ-
ically, the residual activity of VHH was measured at a protein
concentration of 1.3 g/ml, corresponding to 100 nM. For each
measurement, the data were at least duplicated using a multiple
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channel flow cell, and data were averaged. Errors were calcu-
lated as standard deviations.
Analytical Gel Permeation Chromatography and SDS-
PAGE—Wild-type VHH samples (10 M) with or without heat
treatment were first filtered by spin column with a 0.45-m
PVDF membrane (Ultrafree-MC, EMD Millipore Corp., Bil-
lerica, MA). The samples (200 l; 10 M) were analyzed using
Superose 6 10/300 GL (GE Healthcare) equilibrated with
HBS-EP buffer at room temperature. In addition, 10 l of the
same samples was subjected to SDS-PAGE on 10 –20% gels
(Oriental Instruments Ltd., Tokyo, Japan) with or without
dithiothreitol as a reducing reagent.
MALDI-TOF Mass Spectra of Heat-treated VHH and the
N52S/N74S/N84T Mutant—Wild-type VHH and the N52S/
N74S/N84T mutant (5 M) were subjected to 40 cycles of heat-
ing (90 °C)-cooling (20 °C) or to a continuous 1,600-min incu-
bation at 90 °C in HBS-EP buffer. The samples were mixed
volume to volume with 10 mg/ml synaptic acid (Nacalai
Tesque, Kyoto, Japan) in 80% acetonitrile with 0.1% 2,2,2-tri-
fluoroacetic acid. MALDI-TOF mass spectra were obtained
using a Microflex AI instrument.
Measurement of Equilibrium Thermal Unfolding of VHH and
Mutants—Circular dichroism spectra were measured using a
J-820 spectropolarimeter (Jasco) and a 1-mm cell in 10 mM
HEPES (pH 7.4), 150 mM NaCl, and 0.005% surfactant P20,
which is HBS-EP buffer without EDTA, at a protein concentra-
tion of 25 M unless otherwise noted. Thermal unfolding of
VHH and mutants with or without heat treatment was moni-
tored as the change in ellipticity at 235 nm under the above
conditions. After the first thermal unfolding, the consecutive
second thermal unfolding curve was almost identical to that of
the first run for both wild-type and mutant VHH with and with-
out heating-cooling cycles, confirming the reversibility of VHH
from the thermally unfolded state. DSC measurements of VHH
were made using a VP-DSC microcalorimeter (MicroCal,
Northampton, MA) in HBS-EP buffer. For both CD and DSC
measurements, the heating rate was 1 °C/min.
Treatment of Heat-treated VHH with Denaturant—To
unfold heat-treated VHH, 400 mg of solid Gdn-HCl was added
to 300 l of wild-type VHH (40 M) in HBS-EP buffer, resulting
in a final concentration of denaturant of 6 M. The samples
were then dialyzed against 10 mM HEPES (pH 7.4), 150 mM
NaCl, and 0.005% surfactant P20. The VHH concentrations of
dialyzed samples were estimated using absorbance at 280 nm
and comparison with that of samples with known VHH con-
centrations. CD spectra of dialyzed samples were measured at a
protein concentration of 14 M at 37 °C without dilution or
concentration. The fraction of residual activity was evaluated
against the activity of Gdn-HCl-treated VHH without heat
treatment to minimize potential experimental error caused by
an additional denaturant-induced unfolding and refolding step.
RESULTS
Irreversible Denaturation of VHH Was Induced by Iterative
Heat-induced Heating-Cooling Cycles and Continuous Treat-
ment at a High Temperature—The impact of folding/unfolding
intermediates on the irreversible denaturation of VHH was
determined. The residual antigen binding activity after iterative
heating (90 °C for 5 min)-cooling (20 °C for 5 min) cycles or
continuous incubation at 90 °C was measured using SPR (Figs. 1
and 2A). VHH-H14, the VHH clone used in these experiments,
recognizes hCG and has been widely used as a model of VHH
molecules (5, 6, 10, 27, 32, 33, 38 – 40). Its midpoint tempera-
ture of thermal unfolding (Tm) is 65 °C, and other VHHs
reported are considered to be unfolded at 90 °C (7, 31). Thus,
we chose 90 °C as the heating temperature. The proteins were
treated for 5 min at 90 °C in heating-cooling cycles; the number
of cycles multiplied by 5 min corresponded to the continuous
incubation time. If the folding/unfolding intermediates are
important for denaturation, the residual activity after a certain
number of cycles should be lower than the activity after contin-
uous incubation for the same total heating time. However, the
denaturation curves as a function of the number of cycles and
the continuous incubation time were almost identical (Fig. 2A).
Our results suggested that VHH denaturation did not depend
on aggregation and/or misfolding of VHH folding/unfolding
intermediates in our experimental conditions.
Next, VHH samples were treated with various heating tem-
peratures ranging from 40 to 90 °C (Fig. 2B). In these experi-
ments, 80 cycles and 400 min of continuous heating were
selected in which 20% of the antigen binding activity
remained when heating temperature was 90 °C (Fig. 2A). Heat-
induced denaturation of VHH was observed at 70 °C and above,
but no significant denaturation was observed at 60 or 65 °C. At
these temperatures, which are close to the Tm (65 °C), 20 –
50% of the molecules were unfolded (32, 33) (see also Fig. 8B).
Because an equilibrium reaction between the native and
unfolded states often occurred at 60 and 65 °C, this finding also
supported the minor role of the folding/unfolding intermedi-
ates in VHH denaturation. More than 90% of the molecules
were already unfolded at 70 °C, but increasing the temperature
led to a decrease in VHH residual activity, suggesting that the
thermal load of the unfolded state may cause denaturation,
whereas higher temperatures may accelerate it. Indeed, at a low
temperature of 37 °C, VHH remained fully active for 1 year in
solution (Fig. 2B, inset).
The VHH protein used in the above experiments was recov-
ered from inclusion bodies and refolded; thus, it may have dif-
ferent properties, such as refolding ability and tendency to
aggregate, than VHH protein recovered from soluble fractions.
However, soluble VHH expressed in E. coli presented an iden-
tical denaturation curve against continuous heating compared
with that of the VHH protein obtained from inclusion bodies
(Fig. 3A), confirming that the preparation of VHH did not sub-
stantially affect our experimental result.
For comparison, anti--lactamase VHH was also subjected
to heat-induced denaturation by the heating-cooling cycles and
continuous incubation (Fig. 3B). Similar to anti-hCG VHH,
denaturation curves of anti--lactamase VHH induced by heat-
ing-cooling cycles and continuous incubation were almost
identical. It should be noted that residual activities after a heat
treatment less than 25 min or five cycles were 10% higher
than that of non-treated sample, and this phenomena would
make further analysis ambiguous. Thus, anti-hCG VHH was
chosen as a representative of VHH for further experiments.
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A Unimolecular Reaction Was Responsible for the Irreversible
Denaturation of VHH—The elimination of active VHH by heat
treatment can be simulated by a single exponential equation:
Fraction of residual activity  exp(kden  Time or Cycles)
where kden is the first-order kinetic constant of denaturation
(Fig. 2A). The agreement between empirical data and the first-
order kinetic curve suggested that heat-induced irreversible
denaturation of VHH could be approximated by a first-order
reaction kinetic.
VHH heat-induced irreversible denaturation was only
slightly dependent on protein concentration (range tested, 0.6
g/ml to 1.3 mg/ml) (Fig. 4A). The marginal effect of protein
concentration indicated that heat-induced denaturation
resulted mainly from a unimolecular reaction and not from
aggregation of the proteins. The proteins were subjected to 40
cycles in which 40% of the antigen binding affinity remained
(Fig. 2A).
Even in conditions where VHH completely lost its antigen
binding activity, a considerable amount of VHH monomers was
observed by analytical gel permeation chromatography (Fig.
4B). Samples treated with 40 heating-cooling cycles exhibited
mainly a monomeric single peak in gel permeation chromatog-
raphy analysis, although the peak height was 60% that of
untreated VHH. VHH lost most of its activity when treated for
1,600 min at 90 °C (Fig. 2A). Conversely, the peak correspond-
ing to monomeric VHH was still observed, and the height of
this peak was 25% that of untreated VHH (Fig. 4B). SDS-
PAGE of the heat-treated sample exhibited a smeared band
with the same mobility of monomeric VHH; no other bands
were observed on the gel (Fig. 4C). These results further indi-
FIGURE 1. Experimental design and determination of residual antigen binding activity. A, the samples were subjected to heating-cooling cycles or
continuous incubation as heat treatment. The high temperature (High-Temp) condition was typically 90 °C. All samples were allowed to cool to 20 °C, and their
functional and structural properties were examined. B, typical SPR measurements obtained for standard curves. The broken line indicates the point at 350 s. C,
SPR measurements of samples (1.3 g/ml; 100 nM) treated with a continuous incubation at 90 °C for a given time. The broken line indicates the point at 350 s.
D, standard curve constructed by plotting protein concentrations against SPR values at 350 s obtained in B. The fourth dimension polynomial fitting parameters
were calculated and are indicated at the top left of the panel. E, fractions of residual activity at each time point were estimated from the SPR value at 350 s in C
and the parameters obtained in D. F, to validate the analysis method for evaluation of the heat-induced inactivation of antibody using SPR spectra, the fractions
of residual activities were estimated by using the SPR values at 150, 200, 250, 300, and 350 s. Error bars represent S.D. In B, C, D, E, and F, results of the
histidine-tagged wild-type anti-hCG VHH purified from inclusion bodies are presented as a representative example. GPC, gel permeation chromatography; RU,
resonance units.
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cated that irreversible denaturation of VHH occurred, at least
in part, through a unimolecular reaction.
Chemical Modifications Caused the Irreversible Denatur-
ation of VHH—Because the heat-induced irreversible denatur-
ation of VHH involved a unimolecular process, we hypothe-
sized that chemical modifications of amino acids and/or
monomeric misfolded structures with noncovalent interac-
tions may be related. The latter was excluded by treatment of
the inactivated proteins with a high concentration of denatur-
ant, which is thought to destroy aberrant interactions in mono-
FIGURE 2. Heat-induced irreversible denaturation of anti-hCG VHH by
repetitive heating-cooling cycles or continuous incubation at a high
temperature and denaturation temperature dependence. A, anti-hCG
VHH (1.3 g/ml) was subjected to heating-cooling cycles (circles) or continu-
ous incubation at 90 °C (triangles). The experiments were carried out at pH 7.4
in HBS-EP buffer. In heating-cooling cycles, a given number of reaction seg-
ments, which consisted of heating at 90 °C for 5 min and cooling at 20 °C for 5
min, were repeated. Residual activity at 20 °C was estimated using the
strength of SPR signals compared with that of SPR signals from a series of
diluted, untreated samples and was expressed as a fraction of the corre-
sponding diluted, untreated sample. Because the time for unfolding was 5
min, one cycle corresponded to 5 min of incubation. The solid line represents
a single exponential curve fitted to the VHH time-dependent denaturation
where the first-order kinetic constant kden was 0.0039 min
1 and the time to
reach half of the original activity was calculated to be 178 min. B, VHH (1.3
g/ml) was subjected to 80 heating-cooling cycles (circles) or continuous
incubation (400 min (m); triangles) where the heating temperature ranged from
40 to 90 °C in HBS-EP buffer. Inset, VHH (1.3 g/ml) was incubated at 37 °C for the
indicated time in HBS-EP buffer. In all panels, error bars represent S.D.
FIGURE 3. Heat resistance of anti-hCG VHH with different preparations
and anti--lactamase VHH. A, anti-hCG VHH samples prepared from E. coli
soluble (circles) and insoluble (squares) fractions were subjected to continu-
ous incubation at 90 °C. Both samples were histidine-tagged at their C ter-
mini. B, anti--lactamase VHH was subjected to heating-cooling cycles (cir-
cles) or continuous incubation at 90 °C (triangles). In heating-cooling cycles, a
given number of reaction segments, which consisted of heating at 90 °C for 5
min (m) and cooling at 20 °C for 5 min, were repeated. Both experiments were
carried out at pH 7.4 in HBS-EP buffer at a protein concentration of 1.3 g/ml.
Error bars represent S.D. Sup, supernatant; Ppt, precipitate.
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meric misfolded structures. Samples were unfolded with 6 M
Gdn-HCl and then refolded by extensive dialysis. Gdn-HCl
treatment did not result in the recovery of VHH antigen bind-
ing activity after 40 heating-cooling cycles or 1,600-min heat
treatment (Fig. 5A). In addition, CD spectra of these samples
were unchanged by Gdn-HCl treatment (Fig. 5B).
The mass spectra of the samples subjected to 40 cycles of
heating-cooling or continuous incubation for 1,600 min exhib-
ited a peak at a position similar to the molecular weight of
FIGURE 4. Effects of protein concentration on VHH denaturation and
analysis of the molecular weight of heat-inactivated anti-hCG VHH by
gel permeation chromatography and SDS-PAGE. A, VHH with different
concentrations in HBS-EP buffer were subjected to 40 cycles of heating-cool-
ing cycles (unfolding at 90 °C for 5 min and refolding at 20 °C for 5 min). Error
bars represent S.D. B, room temperature gel permeation chromatography
profiles of VHH without heat treatment, with 40 cycles of heating-cooling
cycles, and with continuous incubation at 90 °C for 1,600 min (m) at a protein
concentration of 10 M. Arrowheads indicate the elution volumes of serum
albumin (67 kDa), ribonuclease A (13.7 kDa), and trypsin inhibitor (6.5 kDa). C,
VHH (10 M) was treated with continuous incubation at 90 °C for 1,600 min
and analyzed using a polyacrylamide gradient gel (5–20%) with or without
reduction with 10 mM dithiothreitol. The numbers on the left of the panel
indicate the molecular weights of marker proteins. mAU, milliabsorbance
units.
FIGURE 5. Effects of a denaturant on heat-inactivated anti-hCG VHH. A,
the amount of residual activity after Gdn-HCl treatment was estimated and
compared with that of VHH without Gdn-HCl treatment. Samples (40 M)
were unfolded using a final concentration of 6 M Gdn-HCl and then dialyzed
against HBS-EP buffer without EDTA to remove the denaturant. Error bars
represent S.D. B, comparison of CD spectra of heat-inactivated samples at
37 °C with or without 6 M Gdn-HCl treatment followed by refolding. m, min-
utes; deg, degrees.
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untreated VHH (12, 641) (Fig. 6). Thus, chemical modifications
such as deamidation, racemization, and/or isomerization of
amino acid residues were considered as potential mechanisms
of denaturation because they induce only minor changes in
molecular weight. These chemical reactions are often observed
on Asn (1, 41– 45); therefore, a VHH mutant with all Asn resi-
dues substituted by other amino acids (N52S/N74S/N84T) was
prepared to evaluate the effects of chemical modifications on
heat-induced denaturation (Fig. 7A). The VHH positions 52,
74, and 84 used here correspond to positions 52, 73, and 82a in
the Kabat numbering scheme (46) and positions 57, 82, and 92
in the IMGT numbering scheme (47), respectively. After heat
treatment, several extra peaks with low molecular weights were
observed. Some of these extra peaks were eliminated by the
replacement of Asn residues (Fig. 6, B and C). Asn residues are
known as hot spots for nonenzymatic peptide bond cleavage at
neutral to alkaline pH (43, 45). These peaks may represent frag-
ments generated by cleavage at the C terminus of Asn residues,
although m/z values were smaller by 30 – 60 than the calcu-
lated molecular weight.
The N52S/N74S/N84T mutant exhibited 50% increased
half-life (274 min) against heat treatment compared with wild-
type VHH (178 min) (Fig. 7B). Although position Asn-52
belongs to the complementarity determining region 2, the
N52S/N74S/N84T mutant had an antigen binding affinity
comparable with that of wild-type VHH (Fig. 7B, inset). Similar
to wild-type VHH, heating-cooling cycles and continuous incu-
bation denaturation curves were identical for the mutant as
well. Thus, the incubation time at 90 °C was a critical factor
determining the irreversible denaturation of the mutant.
Secondary structures of wild-type VHH and N52S/N74S/
N84T were almost identical at 37 °C (Fig. 8A). However, the
thermodynamic stability of N52S/N74S/N84T was slightly
higher than that of wild-type VHH (Fig. 8B). The difference in
Tm between these two proteins was estimated to be 3 °C.
Although the Tm of a previously described mutant, C22W/
A49C/I70C/C96A, was 8 °C lower than that of wild-type
VHH (33), its residual activity after 40 cycles of heat treatment
was comparable with that of wild-type VHH (Fig. 8C). To our
surprise, a highly stable mutant with an additional disulfide
bond, A49C/I70C (31, 33), had markedly lower heat tolerance
than wild-type VHH. These results suggested that the effects of
equilibrium thermodynamic stability against heat-induced
irreversible denaturation were not significant in our experi-
mental conditions. Thus, the increase in tolerance against heat-
induced irreversible denaturation of the N52S/N74S/N84T
mutant occurred as a result of reduced chemical modifications.
Structural Analysis of the Heat-induced Irreversible Denatur-
ation of VHH—Iterative DSC experiments on samples with and
without heat treatment revealed a gradual decrease in the main
heat absorption peak with an increase of the number of heating
cycles (Fig. 9A). This DSC experiment was carried out without
replacing the sample solution from the sample cell to avoid
perturbation of the baseline; therefore, we could compare the
effects of repetitive heating on Cp values. At a high temperature
(85 °C), the Cp values slightly decreased with the increase in the
number of heating cycles (Fig. 9B), indicating that heat treat-
ment barely altered the thermodynamic characteristics of the
unfolded structure. Conversely, at 35 °C, Cp values gradually
increased and reached a Cp similar to that of high temperatures.
This could be explained by the accumulation of unfolded struc-
tures at low temperatures because of the heat treatment. Broad
but distinct heat absorption spectra were observed at 50 °C in
samples that were subjected to 20 and 30 unfolding and refold-
ing cycles. These results indicated that heat treatment reduced
the amount of proteins with intact native structures and
affected the thermodynamic stability represented by the Tm in
addition to affecting the folding ability. A single exponential
equation fitted the change of Cp values at 63 °C against the
number of measurements, suggesting that the decrease of pro-
teins in the native state was a unimolecular reaction.
The reduction in the amount of the native state did not cor-
relate with the residual antigen binding activity (Fig. 10, A and
B). To directly compare the amount of protein in the native
FIGURE 6. MALDI-TOF mass spectra of wild-type and N52S/N74S/N84T
mutant anti-hCG VHH with and without heat treatment. A, MALDI-TOF
mass spectra of wild-type (red) and N52S/N74S/N84T mutant (black) VHH (5
M). B and C, samples were subjected to 40 heating-cooling cycles (B) or
continuous 1,600-min (m) incubation (C) in HBS-EP buffer. The heating tem-
perature was 90 °C. The spectra of wild-type VHH are presented with an offset
of 200 m/z for clarity. The arrows indicate hypothetical fragments resulting
from digestion occurring at the C terminus of Asn residues. In all panels, wild-
type and N52S/N74S/N84T mutant VHH are abbreviated as WT and Mutant,
respectively.
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state and the residual activity, samples were processed using the
same methods as described above to measure their activity.
Heating-cooling cycles were conducted outside of the DSC cell
using a thermal cycler, and a single run of thermal unfolding for
each heat-treated sample was measured using DSC (Fig. 10A).
The heights of the main peaks in the DSC curves, which corre-
sponded to the amount of the VHH with an intact native struc-
ture, were compared with the residual activity estimated by SPR
analysis (Fig. 10B).
The effects of heat treatment on VHH secondary structure
were investigated using CD. The sample preparation for CD
experiments was identical to the sample preparation for resid-
ual activity measurements where the samples were subjected to
heating (90 °C for 5 min)-cooling (20 °C for 5 min) cycles. At
37 °C, VHH secondary structure was reduced as the number of
heating-cooling cycles increased using the thermal cycler (Fig.
10C). CD spectra from samples treated for less than 10 cycles
were similar to each other. As the number of cycles increased,
the CD spectra gradually changed. Although a quantitative esti-
mation of the amount of secondary structures was difficult,
more than half of the secondary structures seemed to remain
after 40 cycles in contrast to the native state fraction, which was
20% when treated in the same conditions as shown for DSC
(Fig. 10B). After 160 and 320 cycles, spectra similar to that of the
thermally unfolded state at 90 °C were observed, suggesting
that repetitive heating-cooling cycles resulted in the inability of
VHH to refold at physiological temperature. VHH thermal
unfolding curves with and without heat treatment followed by
ellipticity at 235 nm indicated that the cooperativity of unfold-
ing curves decreased with the increase in the number of heat-
ing-cooling cycles (Fig. 10D). This change in cooperativity was
consistent with the result obtained by DSC, indicating that heat
treatment decreased thermodynamic equilibrium stability and
generated heterogeneous VHH molecules with various ther-
modynamic equilibrium stabilities.
Denaturation of Other Antibody Fragments—To examine
whether the denaturation of other antibody fragments oc-
curred via a unimolecular reaction similar to VHH, we investi-
FIGURE 7. Effects of replacement of Asn residues in anti-hCG VHH. A, Asn residues 52, 74, and 84 in anti-hCG VHH-H14 were substituted by Ser, Ser, and Thr,
respectively, resulting in the N52S/N74S/N84T mutant. B, N52S/N74S/N84T mutant (100 nM) was treated with heating (90 °C for 5 min)-cooling (20 °C for 5 min)
cycles (black closed box) or continuous incubation at 90 °C followed by refolding at 20 °C for 5 min (black open box). The theoretical curve for N52S/N74S/N84T
(solid line) was fitted using 0.0025 min1 as a first-order kinetic constant kden. From this kden, the half-life of the N52S/N74S/N84T mutant was calculated to be
274 min (m). Data for wild-type VHH treated with continuous incubation and its theoretical curve are presented as red circles and broken line, respectively. The
SPR signals for untreated wild-type (red broken line) and N52S/N74S/N84T (black solid line) VHHs (100 nM) are presented in the inset. In all panels, wild-type and
N52S/N74S/N84T mutant VHHs are abbreviated as WT and Mutant, respectively. Error bars represent S.D. CDR, complementarity determining region.
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gated the heat-induced denaturation of one scFv, three Fabs
(Fig. 11, A and B), and their parental IgGs as controls (Fig. 11C).
All of these antibody fragments and IgGs bound to hCG. First,
the effects of heating-cooling cycles were assessed. The antigen
binding activity of scFv was 50% that of untreated scFv after
the first heating-cooling cycle and gradually decreased as the
heating-cooling cycle number increased (Fig. 11A). The Fabs
showed a slightly stronger tolerance against denaturation by
heating-cooling cycles than parental IgGs (Fig. 11B). Even after
the first heating-cooling cycle, only a trace level of active anti-
body remained in the cases of IgG clone 28A4 and IgG clone
77F12 (Fig. 11C). In contrast, IgG clone 207 was more resistant
to denaturation by heat treatment.
Because the residual activity after the first cycle was too low
for Fabs, only scFv was used for further analysis. Consistent
with the results observed for VHH, the incubation time at 90 °C,
but not the number of cycles, had a dominant effect on the
denaturation of scFv. However, the heat-induced irreversible
denaturation of scFv depended on the protein concentration
(Fig. 11D). Our results indicated that scFv denaturation was
mainly caused by aggregation at high temperatures. In addition,
the denaturation curves suggested that scFv denaturation did
not proceed through a unimolecular reaction. If the denatur-
ation is a unimolecular reaction and 50% of activity is lost in
each cycle or every 5 min, then less than 5% of scFv activity
would remain after five cycles or 25 min of treatment; this value
was estimated by the fifth power of 0.5. However, our experi-
ment showed that 30% of the initial activity of scFv was present
after five cycles or 25 min. The dependence of scFv denatur-
ation on heating temperature was different from that of VHH
(Fig. 11D, inset). In contrast to the monophasic dependence of
VHH, the residual activity of scFv after seven cycles of heat
treatment was lowest at 80 °C and slightly increased with the
increase in heating temperature. Denaturation of both VHH
and scFv started between 65 and 70 °C.
DISCUSSION
VHH folding/unfolding intermediates were not dominant
factors for heat-induced irreversible denaturation. Our experi-
mental results suggested that VHH denaturation was mainly
FIGURE 8. Effects of mutations of anti-hCG VHH on its biophysical charac-
teristics. A, CD spectra of wild-type and N52S/N74S/N84T VHH (25 M) at 37
and 90 °C in HBS-EP buffer without EDTA. B, equilibrium thermal unfolding
curves of wild-type and N52S/N74S/N84T VHH were measured by changes in
ellipticity at 235 nm at a protein concentration of 25 M. Curves fitted by
standard thermodynamic equations (63) are presented as solid lines, and Tm
values of wild-type VHH and N52S/N74S/N84T mutant VHH were estimated
to be 65 and 68 °C, respectively. C, Tm values and residual activities of wild-
type VHH and VHH mutants (100 nM) after 40 heating-cooling cycles. The Tm
values of disulfide mutants C22W/A49C/I70C/C96A (56 °C) and A49C/I70C
(74 °C) are from Hagihara et al. (33). Wild-type and N52S/N74S/N84T mutant
anti-hCG VHH are abbreviated as WT and Mutant, respectively. Error bars rep-
resent S.D. deg, degrees.
FIGURE 9. Structural changes in anti-hCG VHH induced by iterative DSC
measurements. A, repetitive thermal unfolding and refolding in HBS-EP
buffer induced changes in the heat absorption profiles of VHH at 54 M. This
experiment was carried out in a fixed cell without removing the samples from
the DSC equipment. Heat absorption curves were measured while increasing
the temperature at a rate of 1 °C/min. B, changes in Cp at 35 (open circles), 63
(closed triangles), and 85 °C (open squares) induced by repetitive DSC
measurements.
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due to chemical modifications of amino acids because denatur-
ation occurred as a unimolecular reaction irrelevant of the pres-
ence of misfolded monomers and because Asn replacement
increased VHH heat resistance. Various chemical modifica-
tions are often induced by heat in many proteins, and these
modifications are supposed to be an important factor for pro-
tein denaturation. However, chemical modifications are rarely
found to be a major driving force of heat-induced irreversible
denaturation mainly because a number of proteins are inacti-
vated by mixed effects of chemical modifications and aggrega-
tion, which are difficult to discriminate. Although lysozyme
(19, 21) and ribonuclease A (24, 48) are denatured by chemical
modifications at high temperatures, the importance of their
folding/unfolding intermediates on the entire process of dena-
turation remains to be elucidated. Precise discrimination
between the effects of folding/unfolding intermediates and
other factors was achieved in this work by comparing the
impacts of heating-cooling cycles and continuous incubation at
high temperature.
VHH heat-induced irreversible denaturation followed first-
order kinetics, and the concentration of VHH did not signifi-
cantly alter the residual activity of VHH after heat treatment.
Even after the antigen binding ability of VHH was almost com-
pletely lost, considerable amounts of monomeric VHH still
remained. In addition, repetitive unfolding experiments by
DSC revealed that a fraction of intact natively structured mol-
ecules decreased according to first-order kinetics. These data
indicated that the unimolecular reaction caused by heat treat-
ment dominantly affected VHH physical properties. Similar to
VHH, heat-induced irreversible denaturation of lysozyme (21),
ribonuclease A (48), and ovalbumin (49) was reported to be
independent of protein concentration. The unimolecular reac-
tion inducing the irreversible denaturation can be caused by
chemical modifications and/or the generation of misfolded
monomers (11). In the case of VHH, the presence of mono-
meric misfolded molecules was unlikely because the treatment
of inactivated VHH with a denaturant that loosens misfolded
structures did not allow recovery of the antigen binding activity
and its secondary structure.
Asn residues are susceptible to various chemical modifica-
tions (1, 41– 45). We found that the N52S/N74S/N84T mutant
was more resistant to heat-induced irreversible denaturation
than the wild-type VHH protein, suggesting the importance of
chemical modifications for VHH heat resistance. Ahern et al.
(25) also reported that replacement of Asn residues increased
the tolerance of triose-phosphate isomerase to heat. The Asn
mutations reduced protein fragmentation, indicating that these
residues were indeed chemically modified in our experimental
FIGURE 10. Comparison of heat-induced structural changes and denaturation of anti-hCG VHH. A, VHH heat absorption curves. VHH samples (54 M in
HBS-EP buffer) were subjected to cycles of unfolding at 90 °C for 5 min and refolding at 20 °C for 5 min in a thermal cycler. The broken lines represent the
extrapolated linear baseline of the unfolded state. The number of cycles is indicated on each curve. B, comparison between residual activities measured by SPR
and the main peak of heat absorption curves corresponding to intact VHH after heat treatment. The main peaks were estimated by subtracting the baseline
(unfolded state) from the peak heights for all samples, and the resulting heat-treated peak was then divided by the untreated sample peak. Error bars represent
S.D. C, CD spectra of heat-treated VHH at 37 °C in HBS-EP buffer without EDTA. Samples at a protein concentration of 25 M were subjected to cycles of
unfolding at 90 °C for 5 min and refolding at 20 °C for 5 min. For comparison, CD spectra of thermally unfolded intact and heat-denatured VHH at 90 °C are also
shown. D, equilibrium thermal unfolding curves of heat-treated VHH measured by changes in ellipticity at 235 nm. Samples were the same as in C. deg, degrees.
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conditions. Both deamidation and peptide bond cleavage cause
succinimide formation, and the former is followed by sponta-
neous isomerization and racemization (43, 45). Using the hexa-
peptide VYPNLA, Geiger and Clarke (43) demonstrated that
heat treatment at 100 °C and pH 7.4 resulted in 64% isopep-
tides, 22% normal peptides in which Asn was modified to Asp,
and 14% tetrapeptide cleavage products. Fragmentation indi-
cates the occurrence of deamidation-related modifications,
which are approximately 7 times more frequent than fragmen-
tation itself.
Heat treatment decreased the stability and folding ability of
VHH as revealed by CD and DSC. The first-order kinetic model
fitted the decrease of the native state by iterative DSC measure-
ments, and treatment with the denaturant did not allow recov-
ery of secondary structures of denatured VHH. Therefore,
these changes in physical properties were thought to originate
from chemical modifications. Interestingly, the residual frac-
tion of intact native VHH was smaller than the residual fraction
of antigen binding activity. This result indicated that both
native VHH and some of the VHH molecules deteriorated by
heat treatment could maintain their antigen binding ability.
The presence of folded and functional molecules with reduced
thermodynamic stability was supported by our CD experiments
where the amount of secondary structure may be less sensitive
than the amount of protein in the intact native structure. Two
pathways can explain VHH denaturation by chemical modifi-
cations. In the first pathway, accumulation of chemical modifi-
cations may induce gradual loss of stability and folding ability,
which in turn lead to denaturation. The second pathway may
involve modifications of a smaller number of specific amino
acids that are critical for antigen binding activity, such as amino
acids located in the complementarity determining region.
From CD and DSC experiments, the chemical modifications
are suggested to affect the native structure of VHH; i.e. the
chemically modified amino acids alter atomic interactions
found in the native structure. Side chains of Asn residues were
largely exposed to the solvent in the crystal structure (Protein
Data Bank code 1HCV) (39), and the modification in the side
chain may be the cause of minor effects on the structure. How-
ever, main chains were partially buried (Fig. 12, A and B).
Chemical modifications, such as deamidation of Asn, also affect
main chains, and thus Asn chemical modification changes the
van der Waals interaction with main chain atoms and atoms of
other surrounding amino acids. In addition, amides of Asn res-
FIGURE 11. Heat-induced irreversible denaturation of anti-hCG antibody fragments. A–C, scFv (A), Fab (B), and IgG (C) samples (1 g/ml) were subjected
to heating (90 °C for 5 min)-cooling (20 °C for 5 min) cycles at pH 7.4. In addition, dependence of scFv denaturation on incubation time at 90 °C is also shown
(A). Residual activity at 20 °C was estimated using the strength of the SPR signal compared with that of SPR signals from a series of diluted untreated samples
and is presented as the fraction of the corresponding untreated diluted sample. D, concentration-dependent denaturation of scFv was examined. ScFv samples
with the given concentrations were subjected to five cycles of unfolding at 90 °C for 5 min and refolding at 20 °C for 5 min. Inset, scFv (1 g/ml) was subjected
to seven heating-cooling cycles where the heating temperatures ranged from 40 to 90 °C in HBS-EP buffer. Error bars represent S.D. in all panels.
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idues form hydrogen bonds with proximal residues (Fig. 12C).
The chemical modifications of Asn residues alter the van der
Waals interactions and hydrogen bonds of the native structure,
resulting in a change in the stability and function of VHH.
Our results indicated that the mechanisms of heat-induced
irreversible denaturation of scFv and VHH were different.
Denaturation of scFv was affected by protein concentration and
thus controlled by aggregation at high temperatures, whereas
VHH denaturation depended on chemical modifications. In
addition, the temperature dependence of scFv denaturation
was biphasic, therefore making it different from that of VHH,
which was monophasic. Both domains of scFv were thought to
be unfolded at 90 °C, but it is highly possible that at least one
domain is folded or partially folded at temperatures close to
75 °C (50 –53). Demarest and Glaser (54) proposed that aggre-
gation can be caused by interactions of single domains, interac-
tions between variable heavy and variable light fragments of
different molecules, and/or intermolecular tail to tail interac-
tions of exposed base regions of domains. Although our exper-
imental results could not discriminate among the above three
factors, heterologous interactions of heavy and light chain vari-
able domains may explain the significant differences in heat
tolerance between scFv and VHH. Omidfar et al. (9) reported
that whole camelid heavy chain antibody, which has only
homogeneous interactions between heavy chains, was more
stable than conventional IgG and slightly weaker than VHH,
supporting our hypothesis.
Chemical modification of Asn can occur in every protein and
possibly causes adverse effects. It is known that senile cataract is
induced by insoluble eye lens crystallin, and Asn deamidation
was found to be one of the major in vivo modifications of insol-
uble crystallin (55, 56). Formation of amyloid fibril was
enhanced by deamidation of a model peptide of amylin (the
human islet amyloid polypeptide) that forms amyloid deposits
in type 2 diabetes mellitus (57, 58), although it is arguable
whether the chemical modification generally causes amyloid
diseases. In an anthrax vaccine, a spontaneous Asn deamida-
tion of the antigen occurred during storage. It was suggested
that deamidation was the cause of its reduction in effectiveness
of immunogenicity (59). In addition, deamidation is responsi-
ble for much of the heterogeneity of pharmaceutically impor-
tant proteins such as antibodies (1). Conversely, deamidation of
food proteins, such as in whey and wheat, improves their func-
tional properties and makes them more useful for the industry
(60). Deamidation of Asn changes the net charge of food pro-
teins and thus gives a preferable effect on the solubility at neu-
tral pH. As well as the examples above, Asn modifications have
been observed in numerous proteins (61). Quantitative evalua-
tion of the effects of chemical modifications may give clues to
control biological events and improve industrially important
proteins.
By precisely analyzing the entire process of VHH heat-in-
duced irreversible denaturation, we identified chemical modi-
fications of amino acids as a dominant mechanism governing
VHH heat resistance. Chemical modifications are easily con-
trolled compared with aggregation, which depends on the
structure of the folding intermediates and/or the unfolded
state. Indeed, replacement of fragile amino acids simply
increased heat tolerance as shown by the use of the N52S/
N74S/N84T VHH mutant in this study. In addition, amino acid
derivatives and polyamines are known to prevent heat-induced
chemical modifications (62). Our findings enabled a focused
optimization of parameters controlling heat-induced denatur-
ation and will help to elevate VHH heat tolerance.
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